Publications:

Patient-specific molecular alterations are associated with metastatic clear cell renal cell cancer progressing under tyrosine kinase inhibitor therapy.

Oncotarget

Dietz, Steffen S; Sültmann, Holger H; Du, YueJun Y; Reisinger, Eva E; Riediger, Anja Lisa AL; Volckmar, Anna-Lena AL; Stenzinger, Albrecht A; Schlesner, Matthias M; Jäger, Dirk D; Hohenfellner, Markus M; Duensing, Stefan S; Grüllich, Carsten C; Pahernik, Sascha S

Publication Date: 2017-09-26

Variant appearance in text: ALK: G776V

PubMed Link: 29088767

Variant Present in the following documents:

• oncotarget-08-74049-s002.xlsx, sheet 8

View BVdb publication page

A highly specific and sensitive massive parallel sequencer-based test for somatic mutations in non-small cell lung cancer.

Plos One

Inoue, Yoshiaki Y; Shiihara, Jun J; Miyazawa, Hitoshi H; Ohta, Hiromitsu H; Higo, Megumi M; Nagai, Yoshiaki Y; Kobayashi, Kunihiko K; Saijo, Yasuo Y; Tsuchida, Masanori M; Nakayama, Mitsuo M; Hagiwara, Koichi K

Publication Date: 2017

Variant appearance in text: ALK: G776V

PubMed Link: 28448556

Variant Present in the following documents:

• pone.0176525.pdf

View BVdb publication page